Patent ID: 7807347

Claim:
An immuno-PCR method for detecting a molecule of Epstein-Barr Virus Nuclear Antigen 1 (EBNA1) of early-stage nasopharyngeal carcinoma marks, comprising steps of: providing a modified 3-glycidoxypropyltrimethoxysilane (GPTS) glass substrate whereon 50 μL of EBNA1 (10 μg/mL) been immobilized and reacted at 37° for 4 hours; adding a blocking solution having 10 mM Tris/HCl, pH 7.6, 6% skimmed milk power, 0.2% NaN3, 0.05% Tween-20 and 5 mM EDTA, and reacting at 37° for 1 hour; adding a diluted serum and reacting at 37° for 1 hour; adding 50 μL of goat anti-human IgA (0.25 μg/ml of concentration) and reacting at 37° for 1 hour; adding streptavidin (100 ng/ml) and incubating at a room temperature for 30 minutes; adding biotinylated DNA fragments (1 ng/ml) and reacting at 37° for 1 hour; adding a primer pairs with sequences of SEQ ID NO: 1 and SEQ ID NO: 2 for proceeding a polymerase chain reaction; and detecting a target DNA fragments via a electrophoresis method in order to detect the molecule of Epstein-Barr Virus Nuclear Antigen 1 (EBNA1) of early-stage nasopharyngeal carcinoma marks.